Skip to main content
. Author manuscript; available in PMC: 2020 Sep 29.
Published in final edited form as: Invest New Drugs. 2018 Apr 10;36(6):1026–1036. doi: 10.1007/s10637-018-0597-6

Fig. 1.

Fig. 1

Pharmacokinetics of BMS-986115 (parent) and BMT-100948 (metabolite) at steady state (week 3) in patients who received: a once daily regimen (Arm A), b twice weekly regimen (Arm B)